Wendie Hopkins
Andrews University(US)Ludwig Cancer Research(BE)Ludwig Cancer Research(AU)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Monoclonal and Polyclonal Antibodies Research, Radiopharmaceutical Chemistry and Applications, vaccines and immunoinformatics approaches, CAR-T cell therapy research
Most-Cited Works
- A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer.(2003)
- → Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans(2004)438 cited
- → A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors(2007)217 cited
- → A Phase I Trial of Humanized Monoclonal Antibody A33 in Patients with Colorectal Carcinoma: Biodistribution, Pharmacokinetics, and Quantitative Tumor Uptake(2005)124 cited
- The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand.(2004)
- → Regulatory T-Cell–Mediated Attenuation of T-Cell Responses to the NY-ESO-1 ISCOMATRIX Vaccine in Patients with Advanced Malignant Melanoma(2009)118 cited
- → Immunodominant CD4 + responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant(2004)